I-Mab Biopharma
IMAB
#9469
Rank
$55.42 M
Marketcap
$0.68
Share price
-6.87%
Change (1 day)
-62.84%
Change (1 year)

I-Mab Biopharma (IMAB) - Cash on Hand

Cash on Hand as of September 2024 : $0.18 Billion USD

According to I-Mab Biopharma's latest financial reports the company has $0.18 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

I-Mab Biopharma - Cash on Hand chart (from 2024 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$45.59 M-37.1%
2022-12-31$72.49 M-31.16%
2021-12-31$0.10 B-6.33%
2020-12-31$0.11 B369.85%
2019-12-31$23.92 M-38.62%
2018-12-31$38.98 M188.37%
2017-12-31$13.51 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$16.39 M-91.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.43 B 134.25%๐Ÿ‡บ๐Ÿ‡ธ USA